(±)-J 113397
Tocris Bioscience, part of Bio-Techne | Catalog # 2598
Potent and selective NOP antagonist
Key Product Details
Description
Potent and selective NOP antagonist
Product Description
(±)-J 113397 is a potent and selective NOP receptor antagonist (IC50 values are 2.3, 1400, 2200 and > 10000 nM for NOP, κ, μ and δ-opioid receptors respectively). Inhibits nociceptin/orphanin FQ-induced hyperalgesia in the mouse tail-flick test.Product Specifications
Molecular Weight
399.57
Formula
C24H37N3O2
Storage
Desiccate at RT
Purity
≥98% (HPLC)
Chemical Name
(±)-1-[(3R*,4R*)-1-(Cyclooctylmethyl)-3-(hydroxymethyl)-4-piperidinyl]-3-ethyl-1,3-dihydro-2H-benzimidazol-2-one
CAS Number
217461-40-0
PubChem ID
90488772
InChI Key
NLSVMRCGZVSAFK-SDNSQTLOSA-N
SMILES
CCN1C4=C(C=CC=C4)N([C@@H]2CCN(CC3CCCCCCC3)C[C@H]2CO)C1=O.CCN5C8=C(C=CC=C8)N([C@H]6CCN(CC7CCCCCCC7)C[C@@H]6CO)C5=O
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
Solubility
| Solvent | Max Conc. mg/mL | Max Conc. mM | |
|---|---|---|---|
| Solubility | |||
| DMSO | 19.98 | 50 | |
| Ethanol | 19.98 | 50 |
Preparing Stock Solutions
for (±)-J 113397
The following data is based on the product molecular weight 399.57
Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which all affect the solvent volumes required to prepare stock solutions.
| Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
|---|---|---|---|
| 0.5 mM | 5.01 mL | 25.03 mL | 50.05 mL |
| 2.5 mM | 1.00 mL | 5.01 mL | 10.01 mL |
| 5 mM | 0.50 mL | 2.50 mL | 5.01 mL |
| 25 mM | 0.10 mL | 0.50 mL | 1.00 mL |
Calculators
Molarity Calculator
Dilution Calculator
Reconstitution Calculator
Background References
References are publications that support the biological activity of the product.
- Ozaki In vitro and in vivo pharmacological characterization of J-113397, a potent and selective non-peptidyl ORL1 receptor antagonist. Eur.J.Pharmacol. 2000 PMID: 10940356
- Marti The nociceptin/orphanin FQ receptor antagonist J-113397 and L-DOPA additively attenuate experimental Parkinsonism through overinhibition of nigrothalamic pathway. J.Neurosci. 2007 PMID: 17287504
- Kawamoto Discovery of the first potent and selective small molecule opioid receptor-like (ORL1) antagonist: 1-[(3R,4R)-1-cyclooctylmethyl-3-hydroxymethyl-4-piperidyl]-3-ethyl-1,3-dihydro-2H-benzimidazol-2-one (J-113397). J.Med.Chem. 1999 PMID: 10602690
Product Specific Notices for (±)-J 113397
For research use only
Loading...
Loading...